2:22-cv-00556
E.D. Wis.Nov 2, 2022Background
- Pioneer Pet Products owns U.S. Patents 8,813,683 (’683), 9,572,323 (’323), and 9,730,427 (’427) directed to recirculating pet fountains; Pioneer alleges JVST Group’s (Wonder Creature) Amazon-listed fountains infringe.
- JVST filed a declaratory judgment action (22-CV-556) challenging the ’683 patent and alleging tortious interference; Pioneer filed suit (22-CV-839) asserting infringement of the ’683, ’323, and ’427 patents; the court consolidated the matters.
- Pioneer moved for a preliminary injunction to enjoin sale of 14 accused ASIN-identified products, arguing infringement of claim 28 of the ’683 and claim 26 of the ’323 patents.
- JVST defended by challenging validity (anticipation/obviousness, and priority date for the ’683) and denying that the accused products meet claim limitations; it also sought a sur-reply/oral argument.
- The court evaluated likelihood of success, validity/priority disputes, infringement under preliminary claim construction, and irreparable harm; it denied the preliminary injunction and denied JVST’s request for oral argument/sur-reply.
Issues
| Issue | Plaintiff's Argument (Pioneer) | Defendant's Argument (JVST) | Held |
|---|---|---|---|
| Validity of ’683 (priority/anticipation) | ’683 entitled to May 29, 2009 parent priority; thus UK ’173 patent is not prior art | ’173 anticipates ’683; claims invalid | Court: JVST forfeited priority challenge by not addressing continuation-in-part basis; ’173 does not raise a substantial question of invalidity at this stage |
| Infringement of ’683 (claim 28) | Accused products meet claim 28 limitations (basin, cover, upper drinking bowl) | Accused products lack a basin from which a pet can drink and have covers fully overlying the basin; claim is inconsistent | Court: Likely claim construction requires a basin that presents drinking water; Pioneer failed to show likelihood of success on infringement of ’683 |
| Validity & Infringement of ’323 (claim 26) | Claim 26 novel and infringed by accused products, including unique chamfered pump-locating socket | Elements are conventional; chamfered edge is long-known and renders claim obvious/anticipated | Court: JVST failed to show substantial question of invalidity; Pioneer demonstrated a likelihood of success on infringement of ’323 |
| Irreparable harm (need for injunction) | Lost market share, lost future filter sales, and competitive injury justify injunction | Pioneer delayed suit, previously sought licensing (royalty), and lost sales are compensable by damages | Court: Pioneer did not show likely irreparable harm (lost sales/market share compensable; inadequate nexus showing); absence of irreparable harm independently defeats the injunction request |
Key Cases Cited
- Winter v. Natural Res. Def. Council, 555 U.S. 7 (2008) (preliminary injunction requires likelihood of success, irreparable harm, balance of equities, public interest)
- Titan Tire Corp. v. Case New Holland, 566 F.3d 1372 (Fed. Cir. 2009) (patentee must likely prove infringement and withstand validity challenges)
- Revision Military, Inc. v. Balboa Mfg. Co., 700 F.3d 524 (Fed. Cir. 2012) (movant must likely prevail on at least one claim)
- Celsis in Vitro, Inc. v. CellzDirect, Inc., 664 F.3d 922 (Fed. Cir. 2012) (irreparable-harm inquiry: money damages may be inadequate but must show harms not fully compensable)
- Reebok Int'l, Ltd. v. J. Baker, Inc., 32 F.3d 1552 (Fed. Cir. 1994) (loss of the right to exclude does not automatically mean irreparable harm)
- Polymer Techs., Inc. v. Bridwell, 103 F.3d 970 (Fed. Cir. 1996) (presumption of irreparable harm can be rebutted by licensing, cessation, or delay)
- MercExchange, LLC v. eBay, Inc., 401 F.3d 1323 (Fed. Cir. 2005) (willingness to license does not automatically preclude injunction)
- Douglas Dynamics, LLC v. Buyers Prods. Co., 717 F.3d 1336 (Fed. Cir. 2013) (direct competition bears on irreparable-harm analysis)
- Ill. Tool Works, Inc. v. Grip-Pak, Inc., 906 F.2d 679 (Fed. Cir. 1990) (pretrial sales alone do not compel a finding of irreparable harm)
- Mylan Institutional LLC v. Aurobindo Pharma Ltd., 857 F.3d 858 (Fed. Cir. 2017) (no injunction if accused infringer raises substantial question on infringement or validity)